Several hemagglutinins of same serotype for induction of broad immunity against influenza A virus antigenic drift variants: WO2008048984

Bibliography

• Webster RG, Bean WJ, Gorman OT, Evolution and ecology of influenza A viruses. Microbiol Rev 1992;56:152-79
   PubMedGoogle Scholar
• Webster RG. The importance of animal influenza for human disease. Vaccine 2002;20(Suppl 2):16-20
   Google Scholar
• Russell CA, Jones TC, Barr IG, Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses. Vaccine 2008;26(Suppl 4):D31-4
   Google Scholar
• Neirynck S, Deroo T, Saelens X, A universal influenza A vaccine based on the extracellular domain of the M2 protein. Nat Med 1999;5:1157-63
   PubMed Web of Science ®Google Scholar
• Schotsaert M, De Filette M, Fiers W, Saelens X. Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments. Expert Rev Vaccin 2009;8:499-508
   PubMed Web of Science ®Google Scholar
• Jin H, Lu B, Zhou H, Multiple amino acid residues confer temperature sensitivity to human influenza virus vaccine strains (flumist) derived from cold-adapted A/Ann Arbor/6/60. Virology 2003;306:18-24
   PubMed Web of Science ®Google Scholar
• Jin H, Zhou H, Lu B, Kemble G. Imparting temperature sensitivity and attenuation in ferrets to A/Puerto Rico/8/34 influenza virus by transferring the genetic signature for temperature sensitivity from cold-adapted A/Ann Arbor/6/60. J Virol 2004;78:995-8
   PubMed Web of Science ®Google Scholar
• Maassab HF. Adaptation and growth characteristics of influenza virus at 25 degrees C. Nature 1967;213:612-4
   PubMed Web of Science ®Google Scholar
• Ghendon YZ, Markushin SG, Akopova, II, Development of cell culture (MDCK) live cold-adapted (CA) attenuated influenza vaccine. Vaccine 2005;23:4678-84
   PubMed Web of Science ®Google Scholar
• Talon J, Salvatore M, O'Neill RE, Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach. Proc Natl Acad Sci USA 2000;97:4309-14
   PubMed Web of Science ®Google Scholar
• Steel J, Lowen AC, Pena L, Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza. J Virol 2009;83:1742-53
   PubMed Web of Science ®Google Scholar
• Watanabe T, Watanabe S, Kim JH, Novel approach to the development of effective H5N1 influenza A virus vaccines: use of M2 cytoplasmic tail mutants. J Virol 2008;82:2486-92
   PubMed Web of Science ®Google Scholar
• Watanabe S, Watanabe T, Kawaoka Y. Influenza A virus lacking M2 protein as a live attenuated vaccine. J Virol 2009;83:5947-50
   PubMed Web of Science ®Google Scholar
• Stech J, Garn H, Wegmann M, A new approach to an influenza live vaccine: modification of the cleavage site of hemagglutinin. Nat Med 2005;11:683-9
   PubMed Web of Science ®Google Scholar
• Stech J. Attenuated influenza A viruses with modified cleavage sites in hemagglutinin as live vaccines. Expert Rev Vaccin 2008;7:739-43
   PubMed Web of Science ®Google Scholar
• Masic A, Booth JS, Mutwiri GK, Elastase-dependent live attenuated swine influenza A viruses are immunogenic and confer protection against swine influenza A virus infection in pigs. J Virol 2009;83:10198-210
   PubMed Web of Science ®Google Scholar
• St. Jude Children's Research Hospital. Methods and compositions for preparing a universal influenza vaccine. WO2008/048984A2; 2008
   Google Scholar
• Huber VC, Thomas PG, McCullers JA. A multi-valent vaccine approach that elicits broad immunity within an influenza subtype. Vaccine 2009;27:1192-200
   PubMed Web of Science ®Google Scholar
• Smith DJ, Lapedes AS, de Jong JC, Mapping the antigenic and genetic evolution of influenza virus. Science 2004;305:371-6
   PubMed Web of Science ®Google Scholar
• Hoffmann E, Krauss S, Perez D, Eight-plasmid system for rapid generation of influenza virus vaccines. Vaccine 2002;20:3165-70
   PubMed Web of Science ®Google Scholar
• Sutter G, Wyatt LS, Foley PL, A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus. Vaccine 1994;12:1032-40
   PubMed Web of Science ®Google Scholar
• Moss B, Carroll MW, Wyatt LS, Host range restricted, non-replicating vaccinia virus vectors as vaccine candidates. Adv Exp Med Biol 1996;397:7-13
   PubMedGoogle Scholar
• Rimmelzwaan GF, Sutter G. Candidate influenza vaccines based on recombinant modified vaccinia virus Ankara. Expert Rev Vaccin 2009;8:447-54
   PubMed Web of Science ®Google Scholar
• Hoelscher MA, Singh N, Garg S, A broadly protective vaccine against globally dispersed clade 1 and clade 2 H5N1 influenza viruses. J Infect Dis 2008;197:1185-8
   PubMed Web of Science ®Google Scholar
• Hoelscher MA, Garg S, Bangari DS, Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice. Lancet 2006;367:475-81
   PubMed Web of Science ®Google Scholar
• Gao W, Soloff AC, Lu X, Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization. J Virol 2006;80:1959-64
   PubMed Web of Science ®Google Scholar
• Lipatov AS, Webby RJ, Govorkova EA, Efficacy of H5 influenza vaccines produced by reverse genetics in a lethal mouse model. J Infect Dis 2005;191:1216-20
   PubMed Web of Science ®Google Scholar
• Rao S, Kong WP, Wei CJ, Multivalent HA DNA vaccination protects against highly pathogenic H5N1 avian influenza infection in chickens and mice. PLoS One 2008;3:e2432
   PubMed Web of Science ®Google Scholar
• Epstein SL. Control of influenza virus infection by immunity to conserved viral features. Expert Rev Anti Infect Ther 2003;1:627-38
   PubMedGoogle Scholar
• Gabriel G, Garn H, Wegmann M, The potential of a protease activation mutant of a highly pathogenic avian influenza virus for a pandemic live vaccine. Vaccine 2008;26:956-65
   PubMed Web of Science ®Google Scholar
• Horimoto T, Takada A, Iwatsuki-Horimoto K, Kawaoka Y. A protective immune response in mice to viral components other than hemagglutinin in a live influenza A virus vaccine model. Vaccine 2004;22:2244-7
   PubMed Web of Science ®Google Scholar
• Quan FS, Compans RW, Nguyen HH, Kang SM. Induction of heterosubtypic immunity to influenza virus by intranasal immunization. J Virol 2008;82:1350-9
   PubMed Web of Science ®Google Scholar
• Sambhara S, Kurichh A, Miranda R, Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function. Cell Immunol 2001;211:143-53
   PubMed Web of Science ®Google Scholar
• Suguitan AL Jr, McAuliffe J, Mills KL, Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets. PLoS Med 2006;3:e360
   PubMed Web of Science ®Google Scholar
• Takada A, Matsushita S, Ninomiya A, Intranasal immunization with formalin-inactivated virus vaccine induces a broad spectrum of heterosubtypic immunity against influenza A virus infection in mice. Vaccine 2003;21:3212-8
   PubMed Web of Science ®Google Scholar
• Tumpey TM, Renshaw M, Clements JD, Katz JM. Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infection. J Virol 2001;75:5141-50
   PubMed Web of Science ®Google Scholar